Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Nanotess Inc. operates in the Biotechnology & Pharmaceuticals technology area with a focused patenting strategy. The portfolio currently has 1 pending office action in 1 distinct art unit. This indicates a narrow technical focus for the company's current prosecution efforts.
PETRITSCH, AMANDA MICHELLE is the 1 distinct examiner involved, accounting for the 1 busiest examiner pending action. Because the entire pending docket is handled by a single examiner, the prosecution process is highly centralized. This structure means that the entity's current patenting success is tied to a single set of examiner reviews.
For practitioners, this profile suggests that the relationship with the assigned examiner is the most critical factor in the current docket. The lack of diversity in art units and examiners means there is no opportunity to leverage different perspectives within the patent office. A successful outcome requires a thorough understanding of the specific examiner's requirements.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PETRITSCH, AMANDA MICHELLE | 1 | 57.1% | +28.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 16963009 | SURFACE, MATERIAL AND PERSONAL CLEANING FORMULATION COMPRISING NANOSTRUCTURED PARTICLES | PETRITSCH, AMANDA MICHELLE | 97d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 16963009 | SURFACE, MATERIAL AND PERSONAL CLEANING FORMULATION COMPRISING NANOSTRUCTURED PARTICLES | PETRITSCH, AMANDA MICHELLE | 97d overdue |
| Art Unit | Apps |
|---|---|
| 1612 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 16963009 | SURFACE, MATERIAL AND PERSONAL CLEANING FORMULATION COMPRISING NANOSTRUCTURED PARTICLES | PETRITSCH, AMANDA MICHELLE | 1612 | §102§103 | Non-Final OA | 97d overdue | Pending | Jul 17, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial